Skip to content

Critical Limb Ischemia and Transcutaneous Oximetry

Oximetrie Transcutanee et Ischemie Critique

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04369781
Acronym
CITRA
Enrollment
300
Registered
2020-04-30
Start date
2018-10-15
Completion date
2022-10-31
Last updated
2021-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia

Keywords

transcutaneous oxygen pressure

Brief summary

Retrospective analysis of transcutanesou oximetry (Tcpo2) recording for patients referred with suspected critical limb ischemia searching for specific changes in TcpO2 patterns.

Detailed description

* Patients had Tcpo2 recording at the suspected limb and chest level at rest in the lying position. * Provocative tests (leg elevation, leg lowering, oxygen inhalation) were performed to improve the sensitivity of tests. * TcpO2 results were recorded on a 1 Hz bais for of line analysis after anonymization. * We recorded age , gender, weight, height, ongoing treatments , History of cardiac or respiratory disease. Visual and mathematical analysis of the TcpO2 recording at the chest and limb level searching for various indices of TcpO2 variability at rest, or differences in responses between the chest and limb tcpO2 responses to provocative tests..

Interventions

DIAGNOSTIC_TESTtranscutaneous oxygen pressure recording at rest

Recording of limb and chest transcutaneous oxygen pressure

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Referral for suspected critical limb ischemia

Exclusion criteria

* Absence of recording, deny to use medical file

Design outcomes

Primary

MeasureTime frameDescription
Variability of TcpO21 hourStudy of TcpO2 variability

Countries

France

Contacts

Primary ContactPierre ABRAHAM, MD PhD
piabraham@chu-angers.fr+33241353689

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026